Krop og Hormoner ApS: Financial statements 2024
CVR: 38683446
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Krop og Hormoner ApS (CVR 38683446) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -4,875 and a net result of DKK 68,042 compared with DKK 2,627,957 the year before. Equity in the 2024 report amounted to DKK 3,698,216. The solvency ratio was 94.8%.
- Gross Profit
- DKK -4,875
- Profit/Loss
- DKK 68,042
- Equity
- DKK 3,698,216
- Total Assets
- DKK 3,901,690
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -5K | 68K | 3.7M | - |
| 2023 | - | - | 2.6M | 3.6M | 1 |
| 2022 | - | - | -16K | 1M | 1 |
| 2021 | - | -9K | 124K | 1M | 1 |
| 2020 | - | -9K | 801K | 893K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Krop og Hormoner ApS has published its annual report for 2023. The net result was DKK 2,627,957.
About Krop og Hormoner ApS
Krop og Hormoner ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2017. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named GDL Holding ApS. The management consists of Gitte Elbæk Kobbelgaard Dalberg-Larsen. The company is owned by Gitte Elbæk Kobbelgaard Dalberg-Larsen. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 10,394 and a net result of DKK 2,227 compared with DKK 68,042 the year before. Equity in the 2025 report amounted to DKK 3,700,443.